← Every company
Biontech SE SEC Filings
What Biontech SE has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BNTX overview →Filings on file
16
since Sep 9, 2019
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jul 30, 2026 | Annual report 20-F/A | Read ↗ |
| Apr 1, 2026 | Annual report 20-F/A | Read ↗ |
| Mar 10, 2026 | Annual report 20-F | Read ↗ |
| Oct 21, 2025 | Tender offer SC TO-T | Read ↗ |
| Mar 10, 2025 | Annual report 20-F | Read ↗ |
| Mar 20, 2024 | Annual report 20-F | Read ↗ |
| Mar 27, 2023 | Annual report 20-F | Read ↗ |
| Oct 26, 2022 | Annual report 20-F/A | Read ↗ |
| Mar 30, 2022 | Annual report 20-F | Read ↗ |
| Mar 30, 2021 | Annual report 20-F | Read ↗ |
| Jul 21, 2020 | Share offering F-1 | Read ↗ |
| Jul 21, 2020 | Share offering F-1 | Read ↗ |
| Mar 31, 2020 | Annual report 20-F | Read ↗ |
| Feb 3, 2020 | Share offering F-1 | Read ↗ |
| Oct 11, 2019 | Share offering 424B4 | Read ↗ |
| Sep 9, 2019 | Share offering F-1 | Read ↗ |
Source: Biontech SE's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.